Miralles Gines Diego — SEC Form 4 filings

SEC reporting owner CIK 1773413. 6 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2025-03-17 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Artiva Biotherapeutics, Inc. (ARTV)President & Head of R&D35
Contineum Therapeutics, Inc. (CTNM)Director33

Form 4 filings — Miralles Gines Diego

FiledFormIssuerReported transactionsSource
2026-09-114Artiva Biotherapeutics, Inc. (ARTV)Grant/award (A): 45,000 @ $0 · Grant/award (A): 135,000 (derivative) @ $0EDGAR
2026-06-264Contineum Therapeutics, Inc. (CTNM)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2026-05-194Artiva Biotherapeutics, Inc. (ARTV)Grant/award (A): 77,500 @ $0 · Grant/award (A): 232,500 (derivative) @ $0EDGAR
2025-06-264Artiva Biotherapeutics, Inc. (ARTV)Grant/award (A): 13,750 (derivative) @ $0EDGAR
2025-06-264Contineum Therapeutics, Inc. (CTNM)Grant/award (A): 14,750 (derivative) @ $0EDGAR
2025-03-174Contineum Therapeutics, Inc. (CTNM)Grant/award (A): 29,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1773413 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →